DMAC
DiaMedica Therapeutics Inc.
+0.19 (+2.87%)6.82USD121K成交股數368M市值–本益比(近四季)735.5股價營收比–營收年增(近四季)2026-11-11下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 8.2M | 8.0M | 6.7M | 6.4M | 5.8M | 5.7M | 5.0M | 3.9M | 3.7M | 3.7M | 3.3M | 2.5M |
| 銷售管理費用 | 2.3M | 2.5M | 2.5M | 2.6M | 2.2M | 2.5M | 1.9M | 1.7M | 2.1M | 2.2M | 1.9M | 2.2M |
| 營業利益 | −10.5M+31% | −10.5M+29% | −9.2M+34% | −9.0M+60% | −8.0M+39% | −8.1M+39% | −6.9M+33% | −5.6M+19% | −5.7M | −5.8M | −5.2M | −4.7M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −10.1M+32% | −10.0M+30% | −8.7M+39% | −8.6M+68% | −7.7M+49% | −7.7M+49% | −6.3M+40% | −5.1M+14% | −5.2M | −5.2M | −4.5M | −4.5M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋股數 | – | – | – | – | – | – | – | – | – | – | – | – |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 5.1M | 4.9M | 15.6M | 3.3M | 4.1M | 2.6M | 4.1M | 14.1M | 2.1M | 4.5M | 2.2M | 5.8M |
| 應收帳款 | 244K | 301K | 258K | 260K | 161K | 253K | 290K | 391K | 399K | 369K | 310K | 188K |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 45.0M | 53.1M | 61.4M | 57.0M | 31.5M | 38.8M | 52.5M | 56.8M | 49.3M | 54.2M | 58.1M | 62.1M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 股東權益 | 38.3M | 47.2M | 56.1M | 51.6M | 27.2M | 34.0M | 48.0M | 53.4M | 46.3M | 51.1M | 55.6M | 59.7M |
| 負債比 | – | – | – | – | – | – | – | – | – | – | – | – |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −9.1M+27% | – | – | – | −7.1M | – | – | −6.7M | – | – | – |
| 資本支出 | – | 8K | – | – | – | 12K | – | – | 9K | – | – | – |
| 自由現金流 | – | −9.1M+27% | – | – | – | −7.2M | – | – | −6.7M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −32.8M | –% | – | −29.1M |
| FY2024 | – | – | −24.4M | –% | – | −22.1M |
| FY2023 | – | – | −19.4M | –% | – | −18.8M |
| FY2022 | – | – | −13.7M | –% | – | −11.6M |
| FY2021 | – | – | −13.6M | –% | -0.65 | −12.3M |
| FY2020 | – | – | −12.3M | –% | -0.78 | −9.2M |
| FY2019 | – | – | −10.6M | –% | -0.89 | −9.1M |
| FY2018 | 500K | – | −5.7M | -1,146.8% | -0.74 | −5.7M |